October 25, 2024
Oral sulopenem is the first oral penem approved in the US for treating uUTIs in women with limited options.
March 31, 2022
ACC 2022. ACC late-breaking clinical trial sessions begin Sat, April 2, 2022. Our short slide shows highlight the studies of interest to primary care clinicians.
March 31, 2022
At ACC 2022 on Sunday, 4-2, look for studies on icosapent ethyl and alirocumab, landmark research on HFrEF, and a novel anticoagulant for atrial fibrillation.
March 31, 2022
At ACC 2022 on Sunday, 4-2, look for studies on icosapent ethyl and alirocumab, landmark research on HFrEF, and a novel anticoagulant for atrial fibrillation.
February 28, 2022
AAAAI late-breaking science and findings that could change your treatment plan for patients with severe asthma, summarized by our editors for easy access.
December 03, 2021
ADA 2021 Scientific Sessions recap, tests of clinical knowledge, expert interviews, and more in this roundup from Patient Care Online.
February 23, 2021
The MJH Life Sciences COVID-19 Coalition is a partnership with 10 nationally recognized experts. They comment on the issues driving the US response to the pandemic.
November 25, 2020
In episode 5 of Primary Viewpoints, Jonathan Chow, MD, reviews the landmark study findings that patients with COVID-19 taking low-dose aspirin had reduced risk for death.
October 29, 2020
Patrick Moriarty, MD, from the University of Kansas Medical Center, discusses the role of Lp(a) as a risk factor for cardiovascular disease and the phase 3 trials of a potential treatment.
October 12, 2020
Nearly two-thirds of physicians say the COVID-19 pandemic has made them feel more burned out.